GABA-based therapy for autoimmune diabetes (TIDM):GABA(Gamma amminobutryic acid) increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 14/May/2018, 11.58 pm